ArticleEvidence-based complementary and alternative medicine : eCAM2014
Exploring the Anti-Burkholderia cepacia Complex Activity of Essential Oils: A Preliminary Analysis.
Article in Evidence-based complementary and alternative medicine : eCAM, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 33 citations in OpenAlex.
- Essential Oils as Antimicrobial Agents Against WHO Priority Bacterial Pathogens: A Strategic Review of In Vitro Clinical Efficacy, Innovations and Research Gaps.Antibiotics (Basel, Switzerland) · 2025Review
- Antibacterial Activity of a Natural Clay Mineral againstMicroorganisms · 2023Article
- The cypsela (achene) of Echinacea purpurea as a diffusion unit of a community of microorganisms.Applied microbiology and biotechnology · 2021Article
- The Effect of Ten Essential Oils on Several Cutaneous Drug-Resistant Microorganisms and Their Cyto/Genotoxic and Antioxidant Properties.Molecules (Basel, Switzerland) · 2019Article
- Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens.Molecules (Basel, Switzerland) · 2019Review
- Oil nanoencapsulation: development, application, and incorporation into the food market.Nanoscale research letters · 2019Review
- Article
- Antimicrobial activity of essential oils against multidrug-resistant clinical isolates of the Burkholderia cepacia complex.PloS one · 2018Article
- The antibacterial and antifungal activity of six essential oils and their cyto/genotoxicity to human HEL 12469 cells.Scientific reports · 2017Article
- Computational tool for optimizing the essential oils utilization in inhibiting the bacterial growth.Advances and applications in bioinformatics and chemistry : AABC · 2017Article
- Review
- In Vitro Susceptibility of Sporothrix brasiliensis to Essential Oils of Lamiaceae Family.Mycopathologia · 2016Article
- Destruction of Opportunistic Pathogens via Polymer Nanoparticle-Mediated Release of Plant-Based Antimicrobial Payloads.Advanced healthcare materials · 2016Article
- Encapsulation of Cardamom Essential Oil in Chitosan Nano-composites:Frontiers in microbiology · 2016Article
- Linking Bacterial Endophytic Communities to Essential Oils: Clues from Lavandula angustifolia Mill.Evidence-based complementary and alternative medicine : eCAM · 2014Article
- Cytotoxicity and anti-Sporothrix brasiliensis activity of the Origanum majorana Linn. oil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this work we have checked the ability of the essential oils extracted from six different medicinal plants (Eugenia caryophyllata, Origanum vulgare, Rosmarinus officinalis, Lavandula officinalis, Melaleuca alternifolia, and Thymus vulgaris) to inhibit the growth of 18 bacterial type strains belonging to the 18 known species of the Burkholderia cepacia complex (Bcc). These bacteria are opportunistic human pathogens that can cause severe infection in immunocompromised patients, especially those affected by cystic fibrosis (CF), and are often resistant to multiple antibiotics. The analysis of the aromatograms produced by the six oils revealed that, in spite of their different chemical composition, all of them were able to contrast the growth of Bcc members. However, three of them (i.e., Eugenia caryophyllata, Origanum vulgare, and Thymus vulgaris) were particularly active versus the Bcc strains, including those exhibiting a high degree or resistance to ciprofloxacin, one of the most used antibiotics to treat Bcc infections. These three oils are also active toward both environmental and clinical strains (isolated from CF patients), suggesting that they might be used in the future to fight B. cepacia complex infections.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.